“Wegovy and copyright are both GLP-1 receptor agonists and share the same active component, semaglutide, but They may be utilized for various functions and possess unique dosages,” explained Hill.increased chance of reduced blood sugar (hypoglycemia), Primarily those that also just take medicines for diabetic issues like insulin or sulfonylurea